United Services Automobile Association’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-19,213
Closed -$636K 1576
2019
Q2
$636K Sell
19,213
-1,949
-9% -$66.8K ﹤0.01% 1507
2019
Q1
$742K Buy
21,162
+202
+1% +$7.52K ﹤0.01% 1457
2018
Q4
$696K Sell
20,960
-18,645
-47% -$802K ﹤0.01% 1405
2018
Q3
$1.99M Sell
39,605
-13,380
-25% -$661K 0.01% 1130
2018
Q2
$3.17M Sell
52,985
-45,308
-46% -$2.35M 0.01% 996
2018
Q1
$4.5M Buy
98,293
+11,621
+13% +$485K 0.01% 860
2017
Q4
$3.45M Buy
86,672
+28,382
+49% +$1.12M 0.01% 919
2017
Q3
$2.33M Buy
58,290
+17,910
+44% +$775K 0.01% 1020
2017
Q2
$1.74M Sell
40,380
-5,200
-11% -$185K 0.01% 1063
2017
Q1
$1.43M Sell
45,580
-42,520
-48% -$1.14M ﹤0.01% 1052
2016
Q4
$2.23M Sell
88,100
-7,000
-7% -$156K 0.01% 962
2016
Q3
$2.35M Sell
95,100
-6,600
-6% -$149K 0.01% 939
2016
Q2
$2.07M Buy
101,700
+72,600
+249% +$1.29M 0.01% 937
2016
Q1
$444K Buy
+29,100
New +$380K ﹤0.01% 1184

Other funds holding SUPN

United Services Automobile Association's SUPN Position: Q3 2019 in Review

United Services Automobile Association sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 19,213 shares — an estimated $636K sold.

United Services Automobile Association first reported a position in SUPN in Q1 2016 and held it in 14 quarters. The position peaked at $4.5M in Q1 2018. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

  • United Services Automobile Association reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 19,213 Supernus Pharmaceuticals shares in Q3 2019, an estimated $636K.
  • United Services Automobile Association first reported a position in Supernus Pharmaceuticals in Q1 2016 and held it in 14 quarters.
  • United Services Automobile Association's Supernus Pharmaceuticals position peaked at $4.5M in Q1 2018.
  • 243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.